Integra Lifesciences Holdings (IART) Deferred Taxes (2009 - 2026)

Integra Lifesciences Holdings has disclosed Deferred Taxes across 18 years of filings, most recently posting -$4.3 million for Q2 2026.

• In Q2 2026, Deferred Taxes rose 90.33% year-over-year to -$4.3 million; the TTM figure through Jun 2026 stood at -$22.6 million (up 63.94% YoY), while the FY2025 annual figure was -$66.3 million, down 219.64% from the prior year.
• Deferred Taxes came in at -$4.3 million for Q2 2026 at Integra Lifesciences Holdings, down from $1.3 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $4.0 million in Q2 2022 to a low of -$44.8 million in Q2 2025.
• Average Deferred Taxes over 5 years is -$5.9 million, with a median of -$3.6 million recorded in 2024.
• Year-over-year, Deferred Taxes jumped 387.2% in 2022 and slumped 2331.18% in 2025.
• Over 5 years, Deferred Taxes stood at -$6.0 million in 2022, then tumbled by 146.48% to -$14.8 million in 2023, then jumped by 52.94% to -$7.0 million in 2024, then tumbled by 56.67% to -$10.9 million in 2025, then surged by 60.42% to -$4.3 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$4.3 million in Q2 2026, $1.3 million in Q1 2026, and -$10.9 million in Q4 2025.